WuXi PharmaTech Cayman Inc

Type: Company
Name: WuXi PharmaTech Cayman Inc (WuXi PharmaTech (Cayman) Inc)
First reported 8 hours ago - Updated 8 hours ago - 1 reports

Highest Forward Earnings Yield in the Life Sciences Tools & Services Industry Detected for WuXi PharmaTech Cayman (WX, CBM, PKI)

(Financial News Network On) Below are the three companies in the Life Sciences Tools & Services industry with the highest forward earnings yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a ... [Published Individual.com - 8 hours ago]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

PRA winds up for IPO

Perhaps encouraged by the success of its North Carolina neighbor Quintiles ($Q), PRA is making moves toward an IPO of its own, filing a confidential draft registration form with the SEC.The CRO is yet to determine how many shares it will offer and at ... [Published FiercePharma - May 20 2013]
First reported May 19 2013 - Updated May 20 2013 - 1 reports
Agilent Technologies Inc
Agilent Technologies Inc

3 Pharmaceutical Stock Earnings Snapshots

Savient Pharmaceuticals, Inc. ( NASDAQ:SVNT ) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.34 in the quarter versus EPS of $-0.49 in the year-earlier ... [Published Wall St. Cheat Sheet - May 19 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports
WuXi PharmaTech Cayman Inc
WuXi PharmaTech Cayman Inc

Volume Spike Detected in Shares of WuXi...

WuXi PharmaTech Cayman's stock is up 2.6% to $16.84 on heavy trading volume. Today's volume of 751,000 shares tops the average 30-day volume of 231,000 shares. Unusually high volume can signify a potential turning point or validate a breakout. WuXi PharmaTech ... [Published Financial News Network online - May 20 2013]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Agilent Technologies has the Highest...

Below are the three companies in the Life Sciences Tools & Services industry with the s. Earnings yield is useful to compare the relative benefit of owning a stock vs. owning other yield assets such as bonds. If the earnings yield is higher, stocks may ... [Published Financial News Network online - May 17 2013]
First reported May 15 2013 - Updated May 16 2013 - 1 reports
New York Stock Exchange
New York Stock Exchange

Shares of WuXi PharmaTech Cayman Have Risen Above Previous 52-Week High

(Financial News NetwFork O) WuXi PharmaTech Cayman (NYSE:WX) traded at a new 52-week high today of $21.10. So far today approximately 705,000 shares have been exchanged, as compared to an average 30-day volume of 358,000 shares. Over the past year, ... [Published Individual.com - May 15 2013]
First reported May 15 2013 - Updated May 16 2013 - 1 reports

VTG, WX, CPHI, TYPE, ITA, CTGX Are Seasonally Ripe To Go Down In the Next Five Weeks

(M2 PRESSWIRE via COMTEX News Network) -- BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Vantage Drilling Co (AMEX:VTG), Wuxi Pharmatech (Cayman) Inc (NYSE:WX), China Pharma Holdings Inc (AMEX:CPHI), Monotype Imaging Holdings Inc ... [Published PredictWallStreet - May 15 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

WuXi PharmaTech Co., Ltd. Reports Higher Q1; Analyzes Prospects for Its Business

Staying up-to-date has never been simpler. Sign up for the today! by Richard Daverman, PhDMay 14, 2013 -- WuXi PharmaTech released positive financial results for the first quarter of 2013, as revenues increased 11.7% to $132 million. All sectors of the ... [Published BioSpace - May 15 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

UPDATE: Bank of America Raises PO on WuXi PharmaTech After Strong 1Q13 Report

In a report published on Tuesday morning, Bank of America analysts reiterated a Buy rating on WuXi PharmaTech (NYSE: WX), and raised the price objective from $20.00 to $23.00.Bank of America noted in the report, "As the leader in the booming pharmaceutical ... [Published Benzinga.com - May 15 2013]
First reported May 14 2013 - Updated May 15 2013 - 2 reports

WuXi's revenue jumps 11.7% in strong Q1

WuXi PharmaTech CEO Ge LiWuXi PharmaTech ($WX), China's largest CRO, has big expectations for 2013, and the company is well on its way to following through, posting an 11.7% revenue jump in the first quarter.Laboratory services revenue grew 12.5% while ... [Published FiercePharma - May 15 2013]
First reported Apr 28 2013 - Updated Apr 28 2013 - 4 reports

China Biotech In Review WuXi PharmaTech Contributes To Syros Pharma Funding

China Biotech In Review: WuXi PharmaTech Contributes To Syros Pharma FundingHome » Blogs » China Biotech In Review: WuXi PharmaTech Contributes To Syros Pharma FundingDeals and TransactionsRelated Biotechnology, Pharmaceutical and Healthcare NewsSyros ... [Published BioPortfolio - Apr 28 2013]
First reported Apr 22 2013 - Updated Apr 22 2013 - 2 reports

WuXi PharmaTech Cayman Shares Up 18.5% Since SmarTrend's Buy Recommendation (WX)

SmarTrend identified an Uptrend for WuXi PharmaTech Cayman (NYSE:WX) on August 9th, 2012 at $14.53. In approximately 9 months, WuXi PharmaTech Cayman has returned 18.51% as of today's recent price of $17.22.In the past 52 weeks, WuXi PharmaTech Cayman ... [Published Comtex SmarTrend - Apr 22 2013]

Quotes

...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."
VTG, WX, CPHI, TYPE, ITA, CTGX Are Seasonally Ripe To Go Down In the Next Five Weeks [Published PredictWallStreet - May 15 2013]
Bank of America noted in the report, "As the leader in the booming pharmaceutical R&D outsourcing industry, with a broad service offering, expanding capacity and a well established and maintained customer base, WuXi is becoming the CRO of choice for western bio-pharma companies. We expect robust growth in 2013-14, driven by healthy growth in core lab services, expansion in service offerings, contribution from the Vertex contract and toxicology facility."
UPDATE: Bank of America Raises PO on WuXi PharmaTech After Strong 1Q13 Report [Published Benzinga.com - May 15 2013]
"WuXi is succeeding on several fronts at once," CEO Ge Li said in a statement. "We are achieving double-digit, broad-based revenue growth, while effectively improving operating efficiency and controlling our costs to maintain stable margins. We are investing in capabilities and capacity to sustain strong revenue and earnings growth for years to come."
WuXi's revenue jumps 11.7% in strong Q1 [Published FiercePharma - May 15 2013]
...than expected," Tian X Hou, the founder of T H Capital LLC, which compiles research on U S -traded Chinese companies, said by phone from Beijing. "Dangdang’s bottom line is likely to beat consensus due to the effect of business model adjustments since last year."
Dangdang to Home Inns Jump on Profit Optimism: China Overnight [Published BusinessWeek - May 15 2013]

More Content

All (112) | News (74) | Reports (7) | Blogs (13) | Audio/Video (0) | Fact Sheets (2) | Press Releases (16)
sort by: Date | Relevance
Highest Forward Earnings Yield in the Life Scie... [Published Individual.com - 8 hours ago]
PRA winds up for IPO [Published FiercePharma - May 20 2013]
Volume Spike Detected in Shares of WuXi... [Published Financial News Network online - May 20 2013]
3 Pharmaceutical Stock Earnings Snapshots [Published Wall St. Cheat Sheet - May 19 2013]
3 Pharmaceutical Stock Earnings Snapshots [Published Wall St. Cheat Sheet - May 19 2013]
China Biotech In Review: SciClone Pharma In-Lic... [Published Seeking Alpha - May 19 2013]
Agilent Technologies has the Highest... [Published Financial News Network online - May 17 2013]
Shares of WuXi PharmaTech Cayman Have Risen Abo... [Published Individual.com - May 15 2013]
WuXi adding clinical services to open China to ... [Published Outsourcing Pharma - May 15 2013]
WuXi PharmaTech Co., Ltd. Reports Higher Q1; An... [Published BioSpace - May 15 2013]
WuXi PharmaTech Beats on Both Top and Bottom Lines [Published Motley Fool - May 15 2013]
VTG, WX, CPHI, TYPE, ITA, CTGX Are Seasonally R... [Published PredictWallStreet - May 15 2013]
UPDATE: Bank of America Raises PO on WuXi Pharm... [Published Benzinga.com - May 15 2013]
WuXi's revenue jumps 11.7% in strong Q1 [Published FiercePharma - May 15 2013]
Dangdang to Home Inns Jump on Profit Optimism: ... [Published BusinessWeek - May 15 2013]
Dangdang to Home Inns Advance on Outlook: China... [Published Bloomberg - May 15 2013]
WuXi PharmaTech’s “Outperform” Rating Reaffirme... [Published American Banking News - May 14 2013]
WuXi PharmaTech Rating Reiterated by Bank of Am... [Published American Banking News - May 14 2013]
Analysts: Market Is Beginning to Recognize Tesl... [Published Wall St. Cheat Sheet - May 14 2013]
WuXi PharmaTech Co., Ltd. Announces First-Quart... [Published BioSpace - May 14 2013]
UPDATE: Oppenheimer Raises PT on WuXi PharmaTec... [Published Benzinga.com - May 14 2013]
WuXi PharmaTech (Cayman) Management Discusses Q... [Published Seeking Alpha - May 14 2013]
WuXi PharmaTech Stock Rating Reaffirmed by Jeff... [Published American Banking News - May 14 2013]
UPDATE: Jefferies Raises PT on WuXi PharmaTech ... [Published Benzinga.com - May 14 2013]
Wider-than-Expected Loss at ChemoCentryx Zacks [Published Yahoo! Finance - May 14 2013]
WuXi PharmaTech Earnings: Everything You Must K... [Published Wall St. Cheat Sheet - May 14 2013]
Frontrunning: May 14 [Published Zero Hedge - May 14 2013]
Wuxi Pharmatech (Cayman) Inc Reaffirms FY 2013 ... [Published Reuters - May 13 2013]
WuXi PharmaTech (WX): Q1 EPS of $0.35 beats by ... [Published Seeking Alpha - May 13 2013]
WuXi PharmaTech (WX) Updates Q2 Earnings Guidance [Published American Banking News - May 13 2013]
1 2 3 4
In Focus
  •  
Ge Li, Kevin Matras, Li Keqiang, [more]
  •  
New York Stock Exchange, Élan Corporation plc, Bank of America Corp, [more]
  •  
China State Food & Drug Administration, US Securities and Exchange Commission, Tsinghua University, [more]
  •  
Biotechnology, Stocks, Research & Development, [more]
  •  
Xignite Financials, INTUNIV, VYVANSE, [more]
  •  
Wuxi, Shanghai, Boston (Massachusetts, United States), [more]
  •  
China, United States, Macau, [more]
  •  
Diseases, Epidemics, Medication, [more]
  •  
IT, Real Estate, Telecom, [more]
Individual.com, Wall St. Cheat Sheet, American Banking News, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
3 Pharmaceutical Stock Earnings Snapshots [Published Wall St. Cheat Sheet - May 19 2013]
Savient Pharmaceuticals, Inc. ( NASDAQ:SVNT ) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.34 in the quarter versus EPS of $-0.49 in the year-earlier ...
3 Pharmaceutical Stock Earnings Snapshots [Published Wall St. Cheat Sheet - May 19 2013]
Savient Pharmaceuticals, Inc. ( NASDAQ:SVNT ) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.34 in the quarter versus EPS of $-0.49 in the year-earlier ...
Analysts: Market Is Beginning to Recognize Tesl... [Published Wall St. Cheat Sheet - May 14 2013]
Tesla Motors ( NASDAQ:TSLA ): Morgan Stanley believes the market is starting to realize Tesla’s competency in technology, engineering, marketing, and manufacturing, and therefore expects shares to move higher due to regulatory credits, leasing program ...
WuXi PharmaTech Earnings: Everything You Must K... [Published Wall St. Cheat Sheet - May 14 2013]
WuXi PharmaTech (Cayman) Inc. ( NYSE:WX ) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Markets are at 5-year highs! ...
Frontrunning: May 14 [Published Zero Hedge - May 14 2013]
Controversies give Obama new governing headaches ( Reuters ) About that Capex... BHP to Rein In Investment, Chief Says ( WSJ ), considers returning cash to shareholders ( FT ) Bloomberg users’ messages leaked online ( FT ) Japanese mayor sparks China ...
1 2 3

Press Releases

sort by: Date | Relevance
WuXi PharmaTech Announces First-Quarter 2013 Re... [Published Financial Services - May 13 2013]
The Zacks Analyst Blog Highlights: Chicago Brid... [Published Financial Services - May 02 2013]
Zacks.com featured expert Kevin Matras highligh... [Published Financial Services - Apr 24 2013]
The Zacks Analyst Blog Highlights: Elan, Biogen... [Published Financial Services - Apr 23 2013]
WuXi PharmaTech Files 2012 Annual Report on For... [Published PR Newswire - Apr 17 2013]
1 2 3 4
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.